Motley Fool Wealth Management LLC Sells 31,951 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Motley Fool Wealth Management LLC reduced its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 40.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 47,786 shares of the biotechnology company’s stock after selling 31,951 shares during the quarter. Axon Enterprise accounts for approximately 1.5% of Motley Fool Wealth Management LLC’s portfolio, making the stock its 16th largest holding. Motley Fool Wealth Management LLC owned about 0.06% of Axon Enterprise worth $28,300,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of AXON. Vanguard Group Inc. grew its position in Axon Enterprise by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock worth $5,019,886,000 after acquiring an additional 275,959 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Axon Enterprise by 2.0% during the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after purchasing an additional 35,320 shares during the period. GQG Partners LLC bought a new position in shares of Axon Enterprise in the fourth quarter worth approximately $478,349,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Axon Enterprise by 1.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after buying an additional 9,090 shares during the period. Finally, Groupama Asset Managment bought a new stake in Axon Enterprise during the 3rd quarter valued at $200,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on AXON shares. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Needham & Company LLC reiterated a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. Finally, Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $604.67.

Axon Enterprise Trading Up 0.8 %

Shares of NASDAQ AXON opened at $577.18 on Wednesday. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a 50-day moving average of $591.92 and a 200 day moving average of $546.67. The stock has a market cap of $44.23 billion, a P/E ratio of 149.14, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.